La. Admin. Code tit. 46 § XLV-6903

Current through Register Vol. 50, No. 6, June 20, 2024

Section XLV-6903 - Definitions

A. As used in this Subchapter, the following terms shall have the meanings specified.

Anorectic- a drug, medication, or substance used or intended for use as an appetite suppressant.

Schedule II Controlled Substance- any substance so classified under and pursuant to regulations of the Drug Enforcement Administration (DEA), U.S. Department of Justice, 21 CFR §1308 . 12, or any substance which may hereafter be so classified by amendment or supplementation of such regulation.

Schedule III Anorectic- benzphetamine, phendimetrazine, and any other substance now or hereafter classified as a Schedule III controlled substance under and pursuant to Federal DEA regulations, 21 CFR §1308 . 13, and which is indicated for use in the treatment of exogenous obesity by express approval of the U.S. Food and Drug Administration (FDA).

Schedule IV Anorectic- fenfluramine, dexfenfluramine, phentermine, diethylpropion, mazindol, and any other substance now or hereafter classified as a Schedule IV controlled substance under and pursuant to federal DEA regulations, 21 CFR § 1308.14 and which is indicated for use in the treatment of exogenous obesity by express approval of the FDA.

La. Admin. Code tit. 46, § XLV-6903

Promulgated by the Department of Health and Hospitals, Board of Medical Examiners, LR 18:744 (July 1992), amended LR 23:1146 (September 1997).

AUTHORITY NOTE: Promulgated in accordance with R.S. 37:1270(A)(1), 37:1270(B)(6), and 37:1285(B).